References
- Glatter K. A., Graves S. W., Hollenberg N. K., Soszynski P. A., Tao Q.-F., Frem G. J., Williams G. H., Lazarus J. M. Sustained volume expansion and [Na,K]ATPase inhibition in chronic renal failure. Am J Hypertens. 1994; 7: 1016–1025
- Tao Q.-F., Soszynski P. A., Hollenberg N. K., Graves S. W. Specificity of the volume-sensitive sodium pump inhibitor isolated from human peritoneal dialysate in chronic renal failure. Kidney Intl. 1996; 49: 420–429
- Tao Q.-F., Soszynski P. A., Hollenberg N. K., Graves S. W. A sensitive assay for sodium pump inhibition. Clin Chem. 1994; 40: 1977–1978
- Tao Q.-F., Soszynski P. A., Hollenberg N. K., Graves S. W. A sensitive [Na,K]ATPase assay, specific for inhibitors acting via the digitalis-binding site. J Cardiovasc Pharmacol. 1995; 25: 859–863
- Graves S. W., Glatter K., Lazarus J. M., Hollenberg N. K. Volume expansion in renal failure patients: a paradigm for a clinically relevant [Na,K]ATPase inhibitor. J Cardiovasc Pharmacol. 1993; 22(Suppl 2)S54–S57
- Graves S. W., Soszynski P. A., Tao Q.-F., Williams G. H., Hollenberg N. K. A labile endogenous Na-pump inhibitor. The Sodium Pump: Structure, Mechanism, Hormonal Control and its Role in Disease, Steinkopff, Darmstadt, E. Bamberg, W. Schoner. Springer, New York 1994; 771–774
- Hollenberg N. K., Graves S. W. Koch's postulates and the digitalis-like factor. Hypertens Research. 1995; 18: 1–6
- Hollenberg N. K., Graves S. W. Endogenous sodium pump inhibition: current status and therapeutic opportunities. Prog Drug Res. 1996; 46: 9–42
- Xie L. Q., Markides K. E., Lee M. L., Hollenberg N. K., Williams G. H., Graves S. W. Bioanalytical applications of multidimensional open tubular column supercritical fluid chromatography. Chromatographia. 1993; 35: 363–371
- Valdes R., Graves S. W. Protein binding of endogenous digoxin-immunoreactive factor in human serum and its variation with clinical condition. J Clin Endocrinol Metab. 1985; 60: 1135–1143
- Krep H. H., Graves S. W., Price D. A., Lazarus M., Ensign A., Soszynski P. A., Hollenberg N. K. Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with Digibind: stoichiometry and its implications. Am J Hypertens. 1995; 9: 39–46
- Tao Q.-F., Hollenberg N. K., Price D. A., Graves S. W. Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysate. Hypertens. 1997; 29: 815–821
- Haddy F. J., Overbeck H. W. The role of humoral agents in volume expanded hypertension. Life Sci. 1976; 19: 935–948
- Buckalew V. M., Jr., Gruber K. A. Natriuretic hormone. Annu Rev Physiol. 1984; 46: 343–358
- Graves S. W. The sodium pump in hypertension. Curr Opinion Nephrol Hypertens. 1994; 3: 107–111